Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Ligand Pharmaceuticals Stock News

LGNDNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$106.80

At close: Apr 15, 4:00 PM EDT

$106.80

0.000.00%

After Hours: 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Forecast

News

Earnings Ligand Pharmaceuticals (LGND) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Ligand Pharmaceuticals Stock News | NASDAQ:LGND | Benzinga

Get the latest news on Ligand Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Ligand Pharmaceuticals performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, April 10, 2025

Analyst Sees Big Upside In Ligand's Capital-Efficient Biotech Strategy
Vandana Singh - 5 days ago
This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor - 5 days ago
Stifel Initiates Coverage On Ligand Pharmaceu...
Benzinga Newsdesk - 5 days ago

Thursday, February 27, 2025

Ligand Pharmaceuticals shares are trading hig...
Benzinga Newsdesk - Feb 27, 2025, 10:47AM
Ligand Pharmaceuticals Reaffirms FY2025 Outlo...
Benzinga Newsdesk - Feb 27, 2025, 7:03AM
Ligand Pharmaceuticals Q4 2024 Adj EPS $1.27 ...
Benzinga Newsdesk - Feb 27, 2025, 7:01AM
Earnings Scheduled For February 27, 2025
Benzinga Insights - Feb 27, 2025, 3:32AM

Tuesday, February 25, 2025

Ligand Pharmaceuticals Closed A Royalty Finan...
Benzinga Newsdesk - Feb 25, 2025, 7:17AM

Friday, December 27, 2024

Octavio Espinoza Executes Sell Order: Offloads $244K In Ligand Pharmaceuticals Stock
Benzinga Insights - Dec 27, 2024, 10:01AM

Monday, December 23, 2024

Benchmark Reiterates Buy on Ligand Pharmaceut...
Benzinga Newsdesk - Dec 23, 2024, 9:14AM

Monday, December 16, 2024

Barclays Maintains Overweight on Ligand Pharm...
Benzinga Newsdesk - Dec 16, 2024, 9:42AM

Wednesday, December 11, 2024

Demystifying Ligand Pharmaceuticals: Insights From 10 Analyst Reviews
Benzinga Insights - Dec 11, 2024, 1:01PM
RBC Capital Maintains Outperform on Ligand Ph...
Benzinga Newsdesk - Dec 11, 2024, 10:45AM
HC Wainwright & Co. Reiterates Buy on Ligand ...
Benzinga Newsdesk - Dec 11, 2024, 6:37AM

Tuesday, December 03, 2024

John L LaMattina At Ligand Pharmaceuticals Executes Options Exercise, Realizing $169K
Benzinga Insights - Dec 3, 2024, 10:01AM

Tuesday, November 12, 2024

RBC Capital Maintains Outperform on Ligand Ph...
Benzinga Newsdesk - Nov 12, 2024, 9:28AM

Friday, November 08, 2024

Benchmark Maintains Buy on Ligand Pharmaceuti...
Benzinga Newsdesk - Nov 8, 2024, 2:44PM
Barclays Maintains Overweight on Ligand Pharm...
Benzinga Newsdesk - Nov 8, 2024, 1:09PM
Oppenheimer Maintains Outperform on Ligand Ph...
Benzinga Newsdesk - Nov 8, 2024, 11:16AM
A Closer Look at 7 Analyst Recommendations For Ligand Pharmaceuticals
Benzinga Insights - Nov 8, 2024, 10:00AM
HC Wainwright & Co. Reiterates Buy on Ligand ...
Benzinga Newsdesk - Nov 8, 2024, 5:13AM

Thursday, November 07, 2024

Ligand Pharmaceuticals shares are trading hig...
Benzinga Newsdesk - Nov 7, 2024, 2:43PM
Ligand Pharmaceuticals Raises FY24 Adj EPS Gu...
Benzinga Newsdesk - Nov 7, 2024, 7:10AM
Ligand Pharmaceuticals Q3 2024 Adj. EPS $1.84...
Benzinga Newsdesk - Nov 7, 2024, 7:08AM

Thursday, October 31, 2024

HC Wainwright & Co. Reiterates Buy on Ligand ...
Benzinga Newsdesk - Oct 31, 2024, 10:07AM

Monday, October 28, 2024

Barclays Maintains Overweight on Ligand Pharm...
Benzinga Newsdesk - Oct 28, 2024, 10:04AM

Monday, October 21, 2024

Critical Insights From Ligand Pharmaceuticals Analyst Ratings: What You Need To Know
Benzinga Insights - Oct 21, 2024, 9:00AM
Assessing Ligand Pharmaceuticals: Insights From 7 Financial Analysts
Benzinga Insights - Oct 21, 2024, 8:00AM
HC Wainwright & Co. Maintains Buy on Ligand P...
Benzinga Newsdesk - Oct 21, 2024, 5:30AM

Thursday, October 03, 2024

The Latest Analyst Ratings For Ligand Pharmaceuticals
Benzinga Insights - Oct 3, 2024, 1:01PM
Oppenheimer Initiates Coverage On Ligand Phar...
Benzinga Newsdesk - Oct 3, 2024, 8:04AM

Wednesday, September 25, 2024

Insider Move: Matthew E Korenberg Exercises Options, Realizing $704K At Ligand Pharmaceuticals
Benzinga Insights - Sep 25, 2024, 11:01AM

Friday, September 20, 2024

Breaking Update: Octavio Espinoza Engages In Options Exercise At Ligand Pharmaceuticals
Benzinga Insights - Sep 20, 2024, 11:01AM

Thursday, September 19, 2024

Matthew E Korenberg At Ligand Pharmaceuticals Executes Options Exercise, Realizing $260K
Benzinga Insights - Sep 19, 2024, 11:00AM

Friday, September 06, 2024

Ligand Partner Travere Therapeutics Receives ...
Benzinga Newsdesk - Sep 6, 2024, 9:23AM

Tuesday, August 27, 2024

Insider Transaction: Matthew E Korenberg Sells $1.99M Worth Of Ligand Pharmaceuticals Shares
Benzinga Insights - Aug 27, 2024, 11:02AM

Friday, August 16, 2024

Looking Into Ligand Pharmaceuticals's Recent Short Interest
Benzinga Insights - Aug 16, 2024, 9:00AM

Monday, August 12, 2024

Benchmark Maintains Buy on Ligand Pharmaceuti...
Benzinga Newsdesk - Aug 12, 2024, 12:53PM
RBC Capital Reiterates Outperform on Ligand P...
Benzinga Newsdesk - Aug 12, 2024, 12:28PM

Thursday, August 08, 2024

HC Wainwright & Co. Reiterates Buy on Ligand ...
Benzinga Newsdesk - Aug 8, 2024, 6:48AM

Wednesday, August 07, 2024

RBC Capital Reiterates Outperform on Ligand P...
Benzinga Newsdesk - Aug 7, 2024, 1:13PM

Tuesday, August 06, 2024

Ligand Sees 2024 Core Adj. EPS $5.00-$5.50 vs...
Benzinga Newsdesk - Aug 6, 2024, 4:49PM
Ligand Pharmaceuticals Q2 2024 Adj. EPS $1.40...
Benzinga Newsdesk - Aug 6, 2024, 4:27PM

Tuesday, July 30, 2024

Assessing Ligand Pharmaceuticals: Insights From 6 Financial Analysts
Benzinga Insights - Jul 30, 2024, 8:01AM
RBC Capital Initiates Coverage On Ligand Phar...
Benzinga Newsdesk - Jul 30, 2024, 6:03AM

Tuesday, July 09, 2024

Craig-Hallum Maintains Buy on Ligand Pharmace...
Benzinga Newsdesk - Jul 9, 2024, 1:27PM

Monday, July 08, 2024

HC Wainwright & Co. Reiterates Buy on Ligand ...
Benzinga Newsdesk - Jul 8, 2024, 1:58PM
Ligand Pharma to Acquire APEIRON Biologics AG...
Benzinga Newsdesk - Jul 8, 2024, 7:08AM

Friday, June 28, 2024

What 4 Analyst Ratings Have To Say About Ligand Pharmaceuticals
Benzinga Insights - Jun 28, 2024, 3:01PM
Benchmark Reiterates Buy on Ligand Pharmaceut...
Benzinga Newsdesk - Jun 28, 2024, 10:15AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved